Ampyra for Multiple Sclerosis User Reviews (Page 4)
Ampyra has an average rating of 8.0 out of 10 from a total of 71 reviews for the treatment of Multiple Sclerosis. 73% of reviewers reported a positive experience, while 13% reported a negative experience.
Reviews for Ampyra
- Mar...
- Taken for 6 months to 1 year
- January 11, 2022
"I developed kidney stones after several months on this. After stopping it for 6 months, they went away and never came back again. It did nothing for my walking."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Multiple Sclerosis
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about Ampyra (dalfampridine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
"I've been on this medicine for 4 years and am doing really good!"